Author

J. Ang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

M. S. Miller· 2 shared A. Baronina· 1 shared A. C. W. Pike· 1 shared A. Cloake· 1 shared A. Marzok· 1 shared A. Zhang· 1 shared E. P. Carpenter· 1 shared E. Pardon· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. S. Miller

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Respiratory mucosal administration of DNA aptamer nanomaterials protects against antigenically diverse SARS-CoV-2 variants

M. R. D'Agostino, J. Li, Z. Zhang, J. Gu, A. Marzok, J. Ang, K. E. Bujold, S. Afkhami, X. Xia, Y. Li, M. S. Miller

This study shows that DNA aptamer nanomaterials can protect against diverse SARS-CoV-2 variants through respiratory mucosal administration, offering broad neutralization and superior protection compared to monoclonal antibodies.

bioRxiv · May 31, 2024 · PreprintImmunology

Extracellular modulation of TREK-2 activity with nanobodies provides insight into the mechanisms of K2P channel regulation

K. E. J. Rodstrom, A. Cloake, J. Sormann, A. Baronina, K. H. M. Smith, A. C. W. Pike, J. Ang, P. Proks, M. Schewe, I. Holland-Kaye, S. R. Bushell, J. Elliott, E. Pardon, T. Baukrowitz, R. J. Owens, , S. J. Tucker

The paper identifies nanobodies that selectively modulate TREK-2 channel activity and reveals their binding mechanisms through structural analysis.

bioRxiv · Oct 19, 2023Biophysics

Broadly-neutralizing antibodies that bind to the influenza hemagglutinin stalk domain enhance the effectiveness of neuraminidase inhibitors via Fc-mediated effector functions

A. Zhang, H. Chaudhari, Y. Agung, M. D'Agostino, J. Ang, M. S. Miller

This study shows stalk-binding antibodies enhance neuraminidase inhibitor effectiveness through Fc-mediated effector functions, suggesting a synergistic effect in influenza treatment.

bioRxiv · Nov 17, 2021 · PreprintImmunology